Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Lanying Du and Fang Li.
Connection Strength

2.520
  1. MERS Coronavirus: An Emerging Zoonotic Virus. Viruses. 2019 07 19; 11(7).
    View in: PubMed
    Score: 0.833
  2. The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates. Elife. 2021 08 02; 10.
    View in: PubMed
    Score: 0.240
  3. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. J Virol. 2020 02 14; 94(5).
    View in: PubMed
    Score: 0.217
  4. Cryo-Electron Microscopy Structure of Porcine Deltacoronavirus Spike Protein in the Prefusion State J Virol. 2018 02 15; 92(4).
    View in: PubMed
    Score: 0.189
  5. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. J Virol. 2017 Jan 01; 91(1).
    View in: PubMed
    Score: 0.174
  6. Cell Entry of Porcine Epidemic Diarrhea Coronavirus Is Activated by Lysosomal Proteases. J Biol Chem. 2016 Nov 18; 291(47):24779-24786.
    View in: PubMed
    Score: 0.172
  7. Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus. J Virol. 2015 Sep; 89(17):9119-23.
    View in: PubMed
    Score: 0.157
  8. Receptor usage and cell entry of porcine epidemic diarrhea coronavirus. J Virol. 2015 Jun; 89(11):6121-5.
    View in: PubMed
    Score: 0.154
  9. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci U S A. 2014 Aug 26; 111(34):12516-21.
    View in: PubMed
    Score: 0.148
  10. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. J Virol. 2014 Jun; 88(12):7045-53.
    View in: PubMed
    Score: 0.144
  11. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV. J Virol. 2018 09 15; 92(18).
    View in: PubMed
    Score: 0.049
  12. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection. Virology. 2016 12; 499:375-382.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.